The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...
The clearance brings an oral form of Novo’s Wegovy to market ahead of Lilly’s rival medication and kicks off the next phase of an escalating battle for control of the obesity drug market.
Dec 23 (Reuters) - Novo Nordisk shares jumped 10% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival ...
The authorized generic is manufactured by Novo Nordisk, and distributed and sold by Teva. It’s priced at a discount of about 14% to branded Victoza, according to pricing data shared by Erin Fox, a ...
The maker of the blockbuster weight loss and diabetes drugs Wegovy and Ozempic have cut the prices for most versions of these medications. Novo Nordisk dropped the price for injectable Wegovy and ...
By Deena Beasley and Julie Steenhuysen (Reuters) -Studies from Novo Nordisk due early next month will give the strongest ...
The approval of the Wegovy pill comes months before Novo Nordisk rival Eli Lilly and Company expects FDA approval of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback